The Fund's objective is long-term growth utilizing the concept of total return for selecting investments. The Fund's objective is long-term growth utilizing the concept of total return for selecting investments.
GIGA-2339 is the first recombinant polyclonal therapeutic in development to treat and functionally cure chronic hepatitis B virus (HBV) infection; trial initiation expected in Q4 2024 Containing...
XEMBIFY is the first and only 20% subcutaneous immunoglobulin (SCIg) with FDA-approved dosing for treatment-naïve patients, enabling them to go straight to SCIg without initial intravenous therapy...
Biotest, a Grifols Group company, is expected to launch its recently FDA-approved intravenous immunoglobulin in the U.S. in first quarter 2025 Yimmugo will be distributed by Kedrion in the U.S...
With today’s announcement of the transaction completion, Grifols and Haier Group will work together through Shanghai RAAS (SRAAS) to drive synergies that enhance China’s healthcare systemThrough a...
With Biotest-developed Yimmugo, Grifols adds to its remarkable franchise of intravenous and subcutaneous immunoglobulins to meet strong demand Yimmugo, already approved for production and...
The addition of the Clayton site in 2011 marked a new milestone for Grifols, turning the company into a top-three plasma industry leader and setting the stage for sustained business growth The...
Grifols’ in vitro nucleic acid test detects four types of arboviruses, helping mitigate the risk of transfusion-transmitted infections Arboviruses are a growing emerging threat, with changes in...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.34 | 3.6093418259 | 9.42 | 9.87 | 9.42 | 5135 | 9.5960074 | CS |
4 | 0.26 | 2.73684210526 | 9.5 | 9.87 | 9.25 | 3475 | 9.50788063 | CS |
12 | 0.5489 | 5.95911454658 | 9.2111 | 9.87 | 9.01 | 2859 | 9.42404961 | CS |
26 | 0.5 | 5.39956803456 | 9.26 | 9.93 | 8.9 | 2648 | 9.39314333 | CS |
52 | 0.14 | 1.4553014553 | 9.62 | 10.19 | 7.93 | 3145 | 9.08303802 | CS |
156 | 0.39 | 4.16221985059 | 9.37 | 11.25 | 7.8 | 4606 | 9.08901214 | CS |
260 | 1.58 | 19.315403423 | 8.18 | 11.25 | 5.2 | 4873 | 8.39878914 | CS |
Symbol | Price | Vol. |
---|---|---|
SOXLDirexion Daily Semiconductor Bull 3X Shares | $ 38.79 (7.18%) | 85.28M |
SOXSDirexion Daily Semiconductor Bear 3X Shares New | $ 22.07 (-7.39%) | 61.41M |
SPYSPDR S&P 500 | $ 563.68 (0.95%) | 60.05M |
EWZiShares MSCI Brazil ETF | $ 29.83 (-0.10%) | 45.49M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | $ 7.1201 (-2.73%) | 34.01M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.